Glenmede Investment Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$545K Sell
20,708
-103
-0.5% -$2.65K ﹤0.01% 897
2025
Q2
$595K Buy
+20,811
New +$558K ﹤0.01% 862

Other funds holding FMS

Glenmede Investment Management's FMS Position: Q3 2025 in Review

Glenmede Investment Management reduced its Fresenius Medical Care (FMS) stake by 0.49% in Q3 2025, selling an estimated $2.65K and leaving 20,708 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Glenmede Investment Management first reported a position in FMS in Q2 2025 and has held it in 2 quarters since. The position peaked at $595K in Q2 2025. 205 funds tracked by Wall St. Rank hold FMS as of Q3 2025.

  • Glenmede Investment Management held 20,708 shares of Fresenius Medical Care worth $545K as of Q3 2025.
  • Glenmede Investment Management sold 103 Fresenius Medical Care shares in Q3 2025, an estimated $2.65K.
  • Fresenius Medical Care made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #897 holding.
  • Glenmede Investment Management first reported a position in Fresenius Medical Care in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Fresenius Medical Care position peaked at $595K in Q2 2025.
  • 205 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.